Role of PKC and RhoA/ROCK pathways in the spontaneous phasic activity in the rectal smooth muscle

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 304, Issue 8, 2013, Pages

  Singh, Jagmohan ^a   Rattan, Satish ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Phasic activity; Protein kinase C; Rectoanal incontinence; Rho kinase; Smooth muscle

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CALPHOSTIN C; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C INHIBITOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SERINE; THREONINE;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; ENZYME ACTIVITY; ENZYME INHIBITION; INTESTINE MOTILITY; NONHUMAN; PHASIC ACTIVITY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; RECTUM; RECTUM MOTILITY; RECTUM SMOOTH MUSCLE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE;

AMIDES; ANIMALS; CARCINOGENS; ENZYME INHIBITORS; FECAL INCONTINENCE; INDOLES; MALEIMIDES; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NAPHTHALENES; PHORBOL 12,13-DIBUTYRATE; PHOSPHORYLATION; PROTEIN KINASE C; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECTUM; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

EID: 84878533394     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00473.2012     Document Type: Article

References (46)

1. Bayguinov O, Dwyer L, Kim H, Marklew A, Sanders KM, Koh SD. Contribution of Rho-kinase to membrane excitability of murine colonic smooth muscle. Br J Pharmacol 163: 638-648, 2011.
2. Bharucha AE. Outcome measures for fecal incontinence: anorectal structure and function. Gastroenterology 126: S90-S98, 2004.
3. Cao W, Sohn UD, Bitar KN, Biancani P, Harnett KM. MAPK mediates PKC-dependent contractions of cat esophageal and lower esophageal sphincter circular smooth muscle. Am J Physiol Gastrointest Liver Physiol 285: G86-G95, 2003.
4. Chakder S, Sarma D, Rattan S. Mechanism of internal anal sphincter smooth muscle relaxation by phorbol 12,13-dibutyrate. Am J Physiol Gastrointest Liver Physiol 280: G1341-G1350, 2001.
5. Davis PD, Elliott LH, Harris W, Hill CH, Hurst SA, Keech E, Kumar MK, Lawton G, Nixon JS, Wilkinson SE. Inhibitors of protein kinase C.
6. Substituted bisindolylmaleimides with improved potency and selectivity. J Med Chem 35: 994-1001, 1992.
7. De Godoy MA, Rattan S. Role of phospholipase A2 (group I secreted) in the genesis of basal tone in the internal anal sphincter smooth muscle. Am J Physiol Gastrointest Liver Physiol 293: G979-G986, 2007.
8. 2+ channels. BJU Int 104: 690-697, 2009.
9. Eto M. Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 inhibitors. J Biol Chem 284: 35273-35277, 2009.
10. 2+-sensitization of smooth muscle. FEBS Lett 440: 183-187, 1998.
11. Golenhofen K, Mandrek K. Phasic and tonic contraction processes in the gastrointestinal tract. Dig Dis Sci 9: 341-346, 1991.
12. Gong MC, Cohen P, Kitazawa T, Ikebe M, Masuo M, Somlyo AP, Somlyo AV. Myosin light chain phosphatase activities and the effects of phosphatase inhibitors in tonic and phasic smooth muscle. J Biol Chem 267: 14662-14668, 1992.
13. Harnett KM, Cao W, Biancani P. Signal-transduction pathways that regulate smooth muscle function. I. Signal transduction in phasic (esophageal) and tonic (gastroesophageal sphincter) smooth muscles. Am J Physiol Gastrointest Liver Physiol 288: G407-G416, 2005.
14. 2+ channels. Am J Physiol Cell Physiol 270: C1293-C1299, 1996.
15. Hudson CA, Heesom KJ, Lopez BA. Phasic contractions of isolated human myometrium are associated with Rho-kinase (ROCK)-dependent phosphorylation of myosin phosphatase-targeting subunit (MYPT1). Mol Hum Reprod 18: 265-279, 2012.
16. Ihara E, Akiho H, Nakamura K, Turner SR, MacDonald JA. MAPKs represent novel therapeutic targets for gastrointestinal motility disorders. World J Gastroenterol 2: 19-25, 2011.
17. Ihara E, Chappellaz M, Turner SR, MacDonald JA. The contribution of protein kinase C and CPI-17 signaling pathways to hypercontractility in murine experimental colitis. Neurogastroenterol Motil 24: e15-e26, 2012.
18. Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M. Pharmacological properties of Y-27632, a specific inhibitor of Rhoassociated kinases. Mol Pharmacol 57: 976-983, 2000.
19. Kandabashi T, Shimokawa H, Miyata K, Kunihiro I, Eto Y, Morishige K, Matsumoto Y, Obara K, Nakayama K, Takahashi S, Takeshita A. Evidence for protein kinase C-mediated activation of Rhokinase in a porcine model of coronary artery spasm. Arterioscler Thromb Vasc Biol 23: 2209-2214, 2003.
20. Kessler R, Fanestil D. Interference by lipids in the determination of protein using bicinchoninic acid. Anal Biochem 159: 138-142, 1986.
21. 2+ sensitization in rabbit smooth muscle. J Physiol 546: 879-889, 2003.
22. Kobayashi E, Nakano H, Morimoto M, Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 15: 548-553, 1989.
23. Murthy KS. Signaling for contraction and relaxation in smooth muscle of the gut. Annu Rev Physiol 68: 345-374, 2006.
24. Murthy KS, Zhou H, Grider JR, Brautigan DL, Eto M, Makhlouf GM. Differential signalling by muscarinic receptors in smooth muscle: M2-mediated inactivation of myosin light chain kinase via Gi3, Cdc42/ Rac1 and p21-activated kinase 1 pathway, and M3-mediated MLC20 (20 kDa regulatory light chain myosin II) phosphorylation via Rho-associated kinase/myosin phosphatase targeting subunit and protein kinase C/CPI-17 pathway. Biochem J 374: 145-155, 2003.
25. Niiro N, Koga Y, Ikebe M. Agonist-induced changes in the phosphorylation of the myosin-binding subunit of myosin light chain phosphatase and CPI-17, two regulatory factors of myosin light chain phosphatase, in smooth muscle. Biochem J 369: 117-128, 2003.
26. Park SY, Shim JH, Kim M, Sun YH, Kwak HS, Yan X, Choi BC, Im C, Sim SS, Jeong JH, Kim IK, Min YS, Sohn UD. MLCK and PKC involvements via Gi and RhoA protein in contraction by the electrical field stimulation in feline esophageal smooth muscle. Korean J Physiol Pharmacol 14: 29-35, 2010.
27. Patel CA, Rattan S. Spontaneously tonic smooth muscle has characteristically higher levels of RhoA/ROK compared with the phasic smooth muscle. Am J Physiol Gastrointest Liver Physiol 291: G830-G837, 2006.
28. Radomirov R, Ivancheva C, Brading AF, Itzev D, Rakovska A, Negrev N. Ascending and descending reflex motor activity of recto-anal region-cholinergic and nitrergic implications in a rat model. Brain Res Bull 79: 147-155, 2009.
29. Rao SS. Fecal incontinence. In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease, edited by Feldman M, Friedman LS, Brandt LJ. Philadelphia, PA: Saunders Elsevier, 2010.
30. Rattan S, Benjamin P, Maxwell PJ 4th. RhoA/ROCK-kinase: pathophysiologic and therapeutic implications in gastrointestinal smooth muscle tone and relaxation. Gastroenterology 138: 13-18, 2010.
31. Rattan S, De Godoy MA, Patel CA. Rho kinase as a novel molecular therapeutic target for hypertensive internal anal sphincter. Gastroenterology 131: 108-116, 2006.
32. Rattan S, Patel CA. Selectivity of ROCK inhibitors in the spontaneously tonic smooth muscle. Am J Physiol Gastrointest Liver Physiol 294: G687-G693, 2008.
33. Rattan S, Singh J. RhoA/ROCK pathway is the major molecular determinant of basal tone in intact human internal anal sphincter. Am J Physiol Gastrointest Liver Physiol 302: G664-G675, 2012.
34. Sarna SK. In vivo myoelectric activity: methods, analysis, and interpretation. In: Handbook of Physiology. The Gastrointestinal System. Motility and Circulation. Bethesda, MD: Am. Physiol. Soc., 1989, sect. 6, vol. I, part 2.
35. Schaafsma D, Bos ST, Zuidhof AB, Zaagsma J, Meurs H. The inhaled Rho kinase inhibitor Y-27632 protects against allergen-induced acute bronchoconstriction, airway hyperresponsiveness, and inflammation. Am J Physiol Lung Cell Mol Physiol 295: L214-L219, 2008.
36. 2+-dependent and-independent mechanisms. J Physiol 560: 839-855, 2004.
37. Shimamoto H, Shimamoto Y, Kwan CY, Daniel EE. Participation of protein kinase C in endothelin-1-induced contraction in rat aorta: studies with a new tool, calphostin C. Br J Pharmacol 107: 282-287, 1992.
38. Sims SM, Chrones T, Preiksaitis HG. Calcium sensitization in human esophageal muscle: role for RhoA kinase in maintenance of lower esophageal sphincter tone. J Pharmacol Exp Ther 327: 178-186, 2008.
39. Sohn UD, Zoukhri D, Dartt D, Sergheraert C, Harnett KM, Behar J, Biancani P. Different protein kinase C isozymes mediate lower esophageal sphincter tone and phasic contraction of esophageal circular smooth muscle. Mol Pharmacol 51: 462-470, 1997.
40. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83: 1325-1358, 2003.
41. 2+ level in rectal circular muscle of rats. Eur J Pharmacol 353: 67-74, 1998.
42. Terauchi A, Kobayashi D, Mashimo H. Distinct roles of constitutive nitric oxide synthases and interstitial cells of Cajal in rectoanal relaxation. Am J Physiol Gastrointest Liver Physiol 289: G291-G299, 2005.
43. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhame L, Charon D, Kirilovsky J. The bisindolylmaleimide GF109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 24: 15771-15781, 1991.
44. Wald A. Clinical practice. Fecal incontinence in adults. N Engl J Med 356: 1648-1655, 2007.
45. Walsh MP. The involvement of protein kinase C in myosin phosphorylation and force development in rat tail arterial smooth muscle. Biochem J 352: 573-582, 2000.
46. Whitehead WE, Borrud L, Goode PS, Meikle S, Mueller ER, Tuteja A, Weidner A, Weinstein M, Ye W. Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology 137: 512-517, 2009.